1-5 of 5
Heather A. Jacene
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Interim Positron Emission Tomography (iPET) Assessed Using Deauville Score for Patients with Follicular Lymphoma Receiving First-Line Chemoimmunotherapy

Reid W Merryman, MD, Gabriela Spilberg, MD, Patrizia Mondello, MDPhDMSc, Robert A. Redd, MS, Eleanor Taranto, MD, Gulrayz Ahmed, MD, Erin Jeter, Matthew Chase, MD, Gilles Salles, MDPhD, Andrew D Zelenetz, MD PhD, Jennifer R Brown, MD PhD, Jennifer Crombie, MD, Matthew S. Davids, MD, David C. Fisher, MD, Arnold S. Freedman, MD, Eric D Jacobsen, MD, Caron A. Jacobson, MD, Austin I. Kim, MD, Ann S. LaCasce, MD MSc, Benjamin L. Lampson, MD PhD, Samuel Y. Ng, MDPhD, Oreofe Odejide, MD, Philippe Armand, MD PhD, Heather A. Jacene, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-135919
Published: 2020
Journal Articles

Rituximab/Bendamustine and Rituximab/Cytarabine (RB/RC) Induction Chemotherapy for Transplant-Eligible Patients with Mantle Cell Lymphoma: A Pooled Analysis of Two Phase 2 Clinical Trials and Off-Trial Experience

Reid W Merryman, MD, Brad S Kahl, MD, Robert A. Redd, MS, Jad Bsat, BA, Matthew Lewis Chase, Ann S. LaCasce, MD MSc, Arnold S. Freedman, MD, Caron A. Jacobson, MD, David C. Fisher, MD, Samuel Y. Ng, MDPhD, Jennifer L Crombie, MD, Austin I Kim, MD, Oreofe O. Odejide, MD, Matthew S. Davids, MD, Jennifer R. Brown, MD PhD, Heather A. Jacene, Mehta-Shah Neha, Natasha Edwin, MD, Amanda F Cashen, MD, Nancy L. Bartlett, MD, Armin Ghobadi, MD, Philippe Armand, MD PhD, Robin M. Joyce, MD, Eric D Jacobsen, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 145.
https://doi.org/10.1182/blood-2018-99-110520
Published: 2018
Journal Articles

Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy

Clinical Trials & Observations
Bruce D. Cheson, Stephen Ansell, Larry Schwartz, Leo I. Gordon, Ranjana Advani, Heather A. Jacene, Axel Hoos, Sally F. Barrington, Philippe Armand
Journal: Blood
Blood (2016) 128 (21): 2489–2496.
https://doi.org/10.1182/blood-2016-05-718528
Published: 2016
Journal Articles

Phase 2 study of rituximab-ABVD in classical Hodgkin lymphoma

Brief Report
Yvette L. Kasamon, Heather A. Jacene, Christopher D. Gocke, Lode J. Swinnen, Douglas E. Gladstone, Brandy Perkins, Brian K. Link, Leslie L. Popplewell, Thomas M. Habermann, Joseph M. Herman, William H. Matsui, Richard J. Jones, Richard F. Ambinder
Journal: Blood
Blood (2012) 119 (18): 4129–4132.
https://doi.org/10.1182/blood-2012-01-402792
Published: 2012
Journal Articles

Phase I/II Dose-Escalation Study of Tositumomab and Iodine I 131 Tositumomab for Relapsed/Refractory Classical or Lymphocyte-Predominant Hodgkin’s Lymphoma: Feasibility and Initial Safety

Heather A. Jacene, Yvette L. Kasamon, Richard F. Ambinder, Wayne Kasecamp, Donna Serena, Richard L. Wahl
Journal: Blood
Blood (2008) 112 (11): 3059.
https://doi.org/10.1182/blood.V112.11.3059.3059
Published: 2008